Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound   Target Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound

---

Query: EC:1.16.3.1 (ceruloplasmin)
5,074 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A galactose-specific lectin isolated from Ricinus communis beans has been covalently coupled to Sepharose 4B activated with cyanogen bromide. The immobilized lectin retains its polysaccharide-binding property. The Sepharose-lectin can be used for the purification of polysaccharides containing terminal nonreducing galactose. Only a small fraction of 'native fetuin' and 'native ceruloplasmin' are retarded on Sepharose-lectin. On analysis it was observed that they had a lower content of sialic acids as compared to the native and unbound glycoproteins (sialated fractions). However, on desialation, fetuin and ceruloplasmin were completely adsorbed to Sepharose-lectin. The asialoglycoproteins interact strongly with Sepharose-lectin as compared to 'partially sialated glycoproteins'. This has been attributed to the exposure of galactose residues of these glycoproteins on enzymatic desialation. These experiments demonstrated that Sepharose-lectin interacts with glycoproteins through their terminal, non-reducing galactose. On the basis of these experiments it is suggested that Sepharose-lectin can be used as an analytical tool for separation of 'fully sialated glycoproteins' from the 'partially sialated glycoproteins'.
...
PMID:Affinity chromatography of galactose containing biopolymers using covalently coupled Ricinus communis lectin to Sepharose 4B. 5 50

The amino acid sequence of the copper-containing nitrite reductase (EC 1.7.99.3) from Achromobacter cycloclastes strain IAM 1013 has been determined by using peptides derived from digestion with Achromobacter protease I (Lys), Staphylococcus aureus V8 protease (Glu), cyanogen bromide, and BNPS-skatole in acetic acid. The subunit contains 340 amino acids. The identity of the first seven amino acids is tentative. The sequence has been instrumental in the X-ray structure determination of this molecule; in conjunction with the X-ray structure, ligands to a type I copper atom and a type II copper atom (one of each per subunit) have been identified. Comparison of the sequence to those of multi-copper oxidases such as ascorbate oxidase, laccase, and ceruloplasmin [Messerschmidt, A., & Huber, R. (1990) Eur. J. Biochem. 187, 341-352] reveals that each of two domains seen in the X-ray structure is similar to the oxidases and also to the small blue copper-containing proteins such as plastocyanin. The combination of sequence and structural similarity to ascorbate oxidase and sequence similarity to ceruloplasmin leads to a plausible model for the domain structure of ceruloplasmin.
...
PMID:Amino acid sequence of nitrite reductase: a copper protein from Achromobacter cycloclastes. 183 Feb 17

Coagulation factor V is a high molecular weight plasma glycoprotein that participates as a cofactor in the conversion of prothrombin to thrombin by factor Xa. A phage lambda gt11 Hep G2 cell cDNA expression library was screened by using an affinity-purified antibody to human factor V, and 11 positive clones were isolated and plaque-purified. The clone containing the largest cDNA insert contained 2970 nucleotides and coded for 938 amino acids, a stop codon, and 155 nucleotides of 3' noncoding sequence including a poly(A) tail. The coding region includes 651 amino acids from the carboxyl terminus that constitute the light chain of human factor Va and 287 amino acids that are part of the connecting region of the protein. The predicted amino acid sequence agreed completely with 147 amino acid residues that were identified by Edman degradation of cyanogen bromide peptides isolated from the light chain. During the activation of factor V, several peptide bonds are cleaved by thrombin, giving rise to a heavy chain, a connecting fragment(s), and a light chain. The light chain is generated by the cleavage of an Arg-Ser peptide bond. The amino acid sequence of the light chain is homologous (40%) with the carboxyl-terminal fragment (Mr, 73,000) of human factor VIII. Both fragments have a similar domain structure that includes a single ceruloplasmin-related domain followed by two C domains. The carboxyl terminus of the connecting region, however, shows no significant amino acid sequence homology with factor VIII. It is very acidic and contains a number of potential N-linked glycosylation sites. It also contains about 20 tandem repeats of nine amino acids.
...
PMID:Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. 309 20

1. The interpretation of the effects of mixtures of inhibitors on enzymes is considered. 2. The effects of inhibitor mixtures on caeruloplasmin were determined. 3. Fluoride, chloride and cyanate inhibit at one type of site (alpha), whereas bromide and iodide inhibit at another type (beta) present in the same enzyme intermediate. 4. Effects of inhibitor mixtures containing azide or cyanide are consistent with previous indications (Speyer & Curzon, 1968) that these ligands form inhibited complexes with different enzyme intermediates. 5. Isobols of halides or of cyanate with azide indicate that azide inhibits caeruloplasmin by bridging two alpha sites, these being reduced copper atoms. 6. Iodide and cyanate give hyperbolic plots of 1/v against [I]. 7. It is suggested that in the cyanate-inhibited complex the inhibitor binds to a reduced copper atom (alpha site) but that binding of cyanate at another copper atom is sterically prevented. It is suggested that the less bulky alpha-site inhibitors, fluoride and chloride, cause complete inhibition by binding to both of these copper atoms, which can also be bridged by a single azide group. 8. Each halide shows a pattern of effects on caeruloplasmin that is qualitatively distinct from that of other halides.
...
PMID:The effects of inhibitor mixtures and the specific effects of different anions on the oxidase activity of caeruloplasmin. 566 45

A histidine-rich fragment, Cp F5, with a molecular weight of 18,650 was isolated from human ceruloplasmin. It consists of 159 amino acids and contains a possible copper-binding site. The sequence of the first 18 NH2-terminal residues of Cp F5 was determined by automated Edman degradation. Cp F5 was cleaved by cyanogen bromide to produce nine fragments of from 2 to 63 residues. The amino acid sequence of all of the cyanogen bromide fragments was investigated using automated and manual Edman degradation, the fragments being digested with trypsin, chymotrypsin, thermolysin, staphylococcal protease, and pepsin as appropriate. The results, in conjunction with the data on the tryptic peptides reported in the accompanying paper (Kingston, I.B., Kingston, B.L., and Putnam, F.L. (1980) J. Biol. Chem. 255, 2886-2896), establish the complete amino acid sequence of Cp F5.
...
PMID:Primary structure of a histidine-rich proteolytic fragment of human ceruloplasmin. I. Amino acid sequence of the cyanogen bromide peptides. 698 29

Amino acid sequence studies of tryptic peptides isolated from a histidine-rich fragment (Cp F5) of human ceruloplasmin are described. Nineteen tryptic peptides were isolated from unmodified Cp F5 and five tryptic peptides were isolated from citraconylated Cp F5. These peptides, together with the cyanogen bromide fragments reported previously, allowed the assembly of the complete sequence of Cp F5. The fragment has 159 residues and a molecular weight of 18,650; it lacks carbohydrate, is rich in histidine, and contains 1 free cysteine that may be part of a copper-binding site. Human ceruloplasmin is a single polypeptide chain with a molecular weight of about 130,000 that is readily cleaved to large fragments by proteolytic enzymes; the relationships of Cp F5 to intact ceruloplasmin and to structural subunits earlier proposed is described. Cp F5 probably is an intact globular domain that is attached to the COOH-terminal end of ceruloplasmin by a labile interdomain peptide bond.
...
PMID:Primary structure of a histidine-rich proteolytic fragment of human ceruloplasmin. II. Amino acid sequence of the tryptic peptides. 698 30

Serum ceruloplamin levels were measured and Badin's cetrimonium tests (selective precipitation of serum glycoproteins with cetrimonium bromide) were performed after delivery in 72 out of 350 sera previously collected during the 4th-5th months of pregnancy. Thirty-six of the 72 sera were obtained from women whose pregnancy ended with toxaemia, and 36 from women chosen at random whose pregnancy ended normally. In women who developed toxaemia at 8-9 months, ceruloplasmin levels and cetrimonium test values were often higher at 4-5 months than in correlation between assays and tests. Ceruloplasmin determinations and cetrimonium tests therefore provide different types of information on the latent pathological condition which precedes toxaemia, but their predictive values must be taken jointly.
...
PMID:[Serum ceruloplasmin levels and cetrimonium tests in pregnancy]. 714 67

Quaternary monophosphonium compound 1-triphenyl phosphoniomethyl naphthalene bromide stabilizes blood serum samples and preserves the activity of ceruloplasmin (CP 1.16.3.1) intact for 30 days. For preparing the reference material, 10 ml of serum is added to 190 ml of 1.55 mM solution of this compound, left for 24 h at 4-8 degrees C, poured in small flasks, stored at the same temperature, and used as reference material as needed for checking up the correctness of ceruloplasmin measurements in biochemical laboratories.
...
PMID:[Materials for performing external quality control of the measurement of ceruloplasmin activity]. 962 79

The ceruloplasmin activity in bioassays of donor blood serum, preserved at the temperature of 4-8 degrees C, decreases progressively, beginning from the third day of experiment. Freezing of bioassays is accompanied by similar changes, since this enzyme belongs to cryounstable proteins. It has been found out that the 1-triphenylphosphonomethylnaphthalene bromide in concentrations 1.03-2.58 mmol/l stabilizes ceruloplasmin and preserves its activity unchanged in biologic fluids during 30 days of observation. Having used this fluid we have created a delayed method of determining this enzyme which may be used with the aim of studying metabolic processes in the human body of spacemen, submarine crews, members of arctic, antarctic and other expeditions which cannot be accompanied by a biochemical laboratory.
...
PMID:[Delayed determination of ceruloplasmin activity in donors' blood serum after adding chemical stabilizer]. 984 52

Latent ceruloplasmin activity was revealed in 5% of homogenates of the frontal lobes of the albino rats' brain. While assessing the activity of this enzyme in the investigated assays in the dynamics of their storage at 4-8 degrees C, the value under study continuously increased and on the 14th day of the experiment it reached 137% of the initial values. 1-Triphenylphosphoniomethylnafthalene bromide did not exert any effect on the dynamics of changes of ceruloplasmin activity in biological assays.
...
PMID:[Latent ceruloplasmin activity in the frontal lobe of albino rat brains]. 984 72


1 2 Next >>

---